Valuation Pfizer Cinnober Boat

Stocks

Real-time Estimate Tradegate 09:22:58 2026-10-05 EDT			5-day change	1st Jan Change
24.73 ^EUR	0.00%		0.00%	-

07:02am	Vaxcyte Reports Bacterial-Infection Vaccine Met Primary Endpoints in Phase 3 Trial	DJ
06:42am	Vaxcyte shares surge as pneumococcal vaccine meets main trial goals	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	331,440	287,626	162,560	150,345	141,574	158,451	-	-
Change	-	-13.22%	-43.48%	-7.51%	-5.83%	11.92%	-	-
Enterprise Value (EV) ¹	338,807	300,723	221,758	194,219	192,773	205,934	199,431	195,610
Change	-	-11.24%	-26.26%	-12.42%	-0.74%	6.83%	-3.16%	-1.92%
P/E	15.3x	9.37x	77.8x	18.8x	18.3x	17.5x	13.6x	16x
PBR	4.3x	3x	1.83x	1.7x	1.64x	1.81x	1.8x	1.77x
PEG	-	0.2x	-0.8x	0x	-5.16x	1.1x	0.5x	-1.1x
Capitalization / Revenue	4.08x	2.87x	2.78x	2.36x	2.26x	2.55x	2.65x	2.88x
EV / Revenue	4.17x	3x	3.79x	3.05x	3.08x	3.31x	3.33x	3.55x
EV / EBITDA	13.3x	7.1x	14.2x	6.74x	6.75x	8.47x	8.26x	9.28x
EV / EBIT	16.7x	8.07x	23.8x	8.91x	8.77x	9.64x	9.62x	10.9x
EV / FCF	11.3x	11.6x	46.3x	19.7x	21.2x	11.2x	10.4x	11x
FCF Yield	8.82%	8.66%	2.16%	5.06%	4.71%	8.93%	9.65%	9.06%
Dividend per Share ²	1.56	1.61	1.65	1.68	1.72	1.721	1.735	1.733
Rate of return	2.64%	3.14%	5.73%	6.33%	6.91%	6.19%	6.24%	6.23%
EPS ²	3.85	5.47	0.37	1.41	1.36	1.586	2.047	1.742
Distribution rate	40.5%	29.4%	446%	119%	126%	109%	84.8%	99.5%
Net sales ¹	81,288	100,330	58,496	63,627	62,579	62,235	59,878	55,064
EBITDA ¹	25,426	42,336	15,590	28,801	28,563	24,303	24,139	21,072
EBIT ¹	20,235	37,272	9,300	21,788	21,971	21,372	20,724	18,015
Net income ¹	21,979	31,372	2,119	8,031	7,771	8,900	11,080	9,884
Net Debt ¹	7,367	13,097	59,198	43,874	51,199	47,484	40,980	37,159
Reference price ²	59.05	51.24	28.79	26.53	24.90	27.80	27.80	27.80
Nbr of stocks (in thousands)	5,612,867	5,613,315	5,646,413	5,666,990	5,685,708	5,699,674	-	-
Announcement Date	2/8/22	1/31/23	1/30/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.74x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.28x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%